header
Image from OpenLibrary

Outcome of children with high-risk neyroblastoma treated with autologous stem cell transplantation / Mahmoud Hammad Mahmoud ; Supervised Mohamed Hany Mohamed Hussein , Alaa Mohamed Elhaddad , Wael Zekri Khaled

By: Contributor(s): Material type: TextTextLanguage: English Publication details: Cairo : Mahmoud Hammad Mahmoud , 2013Description: 139 P. : charts ; 25cmOther title:
  • نتائج علاج الأطفال المصابين بأورام العقد العصبية (النيوروبلاستوما) عالية الخطورة بزراعة النخاع العظمى الذاتى [Added title page title]
Subject(s): Available additional physical forms:
  • Issued also as CD
Dissertation note: Thesis (Ph.D.) - Cairo University - National Cancer Institute - Department of Pediatric Oncology Summary: To analyze the outcome and to identify risk factors associated with transplant outcome regarding the stage of disease and pre-transplant disease status (complete remission, very good partial remission and partial remission). Two years follow up of 51 pediatric patients with high-risk neuroblastoma treated with a multimodal schedule and received HDC with busulfan and melphalan as a our standard conditioning regimen
Tags from this library: No tags from this library for this title. Log in to add tags.
Star ratings
    Average rating: 0.0 (0 votes)
Holdings
Item type Current library Home library Call number Copy number Status Barcode
Thesis Thesis قاعة الرسائل الجامعية - الدور الاول المكتبة المركزبة الجديدة - جامعة القاهرة Cai01.19.05.Ph.D.2013.Ma.O (Browse shelf(Opens below)) Not for loan 01010110060656000
CD - Rom CD - Rom مخـــزن الرســائل الجـــامعية - البدروم المكتبة المركزبة الجديدة - جامعة القاهرة Cai01.19.05.Ph.D.2013.Ma.O (Browse shelf(Opens below)) 60656.CD Not for loan 01020110060656000

Thesis (Ph.D.) - Cairo University - National Cancer Institute - Department of Pediatric Oncology

To analyze the outcome and to identify risk factors associated with transplant outcome regarding the stage of disease and pre-transplant disease status (complete remission, very good partial remission and partial remission). Two years follow up of 51 pediatric patients with high-risk neuroblastoma treated with a multimodal schedule and received HDC with busulfan and melphalan as a our standard conditioning regimen

Issued also as CD

There are no comments on this title.

to post a comment.